You have 9 free searches left this month | for more free features.

Grade IV Astrocytoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Grade III Astrocytoma, Grade IV Astrocytoma, Astrocytoma, Grade IV Trial in Saint Louis (Tadalafil)

Active, not recruiting
  • Grade III Astrocytoma
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 9, 2022

Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

Recruiting
  • Glioblastoma
  • +3 more
  • Nivolumab-Placebo
  • +4 more
  • Los Angeles, California
  • +3 more
Jan 16, 2023

Compliance, Patient, Glioblastoma, Astrocytoma, Grade IV Trial (Psychological intervention)

Not yet recruiting
  • Compliance, Patient
  • +2 more
  • Psychological intervention
  • (no location specified)
Aug 23, 2023

Vascular Habitats Within Astrocytoma Grade 4 at Molecular,

Recruiting
  • Astrocytoma, Grade IV
  • +7 more
    • Valencia, Spain
      Biomedical Data Science Lab. Universitat Politècnica de València
    May 11, 2022

    Supramaximal Resection Versus Maximal Resection for High-Grade

    Recruiting
    • Glioblastoma
    • +11 more
    • Supramaximal resection
    • Maximal safe resection
    • San Francisco, California
    • +7 more
    Nov 1, 2023

    Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

    Completed
    • Glioma
    • +7 more
    • Neural stem cells loaded with an oncolytic adenovirus
    • Duarte, California
    • +1 more
    Dec 28, 2022

    Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)

    Active, not recruiting
    • Astrocytoma, Grade IV
    • +3 more
    • Radiation
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Astrocytoma, Grade IV Trial in Ann Arbor (drug, radiation, procedure)

    Recruiting
    • Recurrent Glioblastoma
    • +5 more
    • Mycophenolate Mofetil
    • +3 more
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Jul 7, 2022

    Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

    Recruiting
    • Astrocytoma, Grade IV
    • +3 more
    • CYNK-001 systemic and Intra cavity administration
    • Duarte, California
    • +5 more
    Jan 20, 2023

    Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)

    Active, not recruiting
    • Glioblastoma
    • +3 more
    • Stereotactic Radiosurgery
    • Lake Success, New York
      Northwell Health Brain Tumor Center
    Feb 3, 2022

    Targeted Pediatric High-Grade Glioma Therapy

    Not yet recruiting
    • High Grade Glioma
    • +8 more
      • Aurora, Colorado
      • +17 more
      May 1, 2023

      Prospective Validation of Imaging Biomarkers Calculated at

      Recruiting
      • Astrocytoma, Grade IV
        • Valencia, Spain
          Universitat Politècnica de València
        Feb 7, 2022

        Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma Trial in Durham (Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed

        Completed
        • Glioblastoma
        • +3 more
        • Unpulsed DCs
        • +6 more
        • Durham, North Carolina
          Duke University Medical Center
        Jan 3, 2022

        Brain and CNS Tumors Trial in Cleveland (aminolevulinic acid, Surgical Resection)

        Completed
        • Brain and Central Nervous System Tumors
        • aminolevulinic acid
        • Surgical Resection
        • Cleveland, Ohio
          University Hospitals Cleveland Medical Center, Case Comprehensiv
        Sep 13, 2021

        Grade II Glioma, Grade III Glioma, Grade IV Glioma Trial in Boston (Microdevice)

        Recruiting
        • Grade II Glioma
        • +7 more
        • Microdevice
        • Boston, Massachusetts
          Brigham and Women's Hospital
        Feb 22, 2021

        Glioblastoma Multiforme, Glioblastoma, Malignant Glioma Trial in Gainesville, Orlando, Durham (pp65-shLAMP DC with GM-CSF,

        Recruiting
        • Glioblastoma Multiforme
        • +4 more
        • pp65-shLAMP DC with GM-CSF
        • +4 more
        • Gainesville, Florida
        • +2 more
        Jan 6, 2022

        Glioblastoma, Grade IV Astrocytoma, Glioblastoma Multiforme Trial in United States (MDNA55)

        Completed
        • Glioblastoma
        • +3 more
        • San Francisco, California
        • +6 more
        Jan 13, 2021

        Astrocytoma, Glioblastoma Trial in Spain, United States (CC-90010)

        Active, not recruiting
        • Astrocytoma
        • Glioblastoma
        • Jacksonville, Florida
        • +8 more
        Dec 14, 2022

        Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

        Recruiting
        • Malignant Glioma of Brain
        • +8 more
        • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
        • Detroit, Michigan
          Henry Ford Health System
        Jan 9, 2023

        Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

        Recruiting
        • Glioblastoma
        • +3 more
        • Adaptive Radiotherapy
        • New York, New York
          Columbia University Irving Medical Center
        Oct 27, 2023

        Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)

        Active, not recruiting
        • Glioma, Malignant
        • +4 more
        • Tampa, Florida
          Moffitt Cancer Center
        Nov 28, 2022

        Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

        Recruiting
        • Anaplastic Astrocytoma, IDH-Wildtype
        • +8 more
        • Quality-of-Life Assessment
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Dec 8, 2022

        Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

        Not yet recruiting
        • Recurrent High Grade Glioma
        • +4 more
        • (no location specified)
        Jan 24, 2023